Abstract
Nanomedicine has emerged as a promising field for the development of targeted drug delivery systems aimed at improving therapeutic outcomes and minimizing side effects. This article provides an overview of recent advancements in nanomedicine, focusing on the use of nanomaterials for targeted drug delivery in the treatment of cancer, neurological diseases, and infectious diseases. We explore the different types of nanomaterials, including liposomes, dendrimers, nanoparticles, and nanorods, and discuss their potential to improve drug solubility, stability, and bioavailability. Furthermore, we examine the challenges associated with the development of targeted delivery systems and highlight future directions for the integration of nanomedicine in clinical applications.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2020 American Journal of Biomedical Engineering